Sutton Wealth Advisors’s Integra LifeSciences IART Stock Holding History

Sutton Wealth Advisors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5	Closed	-$256	–	1683
2022 Q2	$270	Sell	5 -11	-69%	-$661	﹤0.01%	1549
2022 Q1	$1.03K	Buy	16 +9	+129%	+$593	﹤0.01%	1335
2021 Q4	$469	Buy	+7	New	+$474	﹤0.01%	1542
2019 Q2	–	Sell	-789	Closed	-$44K	–	1188
2019 Q1	$44K	Buy	+789	New	+$40.2K	0.03%	330
2018 Q4	–	Sell	-195	Closed	-$12.8K	–	1155
2018 Q3	$12.8K	Hold	195	–	–	0.01%	740
2018 Q2	$12.6K	Sell	195 -793	-80%	-$49.1K	0.01%	770
2018 Q1	$54.7K	Buy	988 +292	+42%	+$15.3K	0.04%	259
2017 Q4	$33.3K	Hold	696	–	–	0.02%	387
2017 Q3	$35.1K	Hold	696	–	–	0.03%	359
2017 Q2	$37.9K	Buy	696 +228	+49%	+$10.9K	0.03%	314
2017 Q1	$19.7K	Hold	468	–	–	0.02%	523
2016 Q4	$20.1K	Hold	468	–	–	0.02%	495
2016 Q3	$19.3K	Hold	468	–	–	0.02%	468
2016 Q2	$18.7K	Hold	468	–	–	0.02%	461
2016 Q1	$15.8K	Buy	+468	New	+$14.6K	0.02%	497

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Sutton Wealth Advisors's IART Position: Q3 2022 in Review

Sutton Wealth Advisors sold out of Integra LifeSciences (IART) in Q3 2022, closing a stake of 5 shares — an estimated $256 sold.

Sutton Wealth Advisors first reported a position in IART in Q1 2016 and held it in 15 quarters. The position peaked at $54.7K in Q1 2018. 282 funds tracked by Wall St. Rank hold IART as of Q3 2022.

Sutton Wealth Advisors reported no remaining Integra LifeSciences position as of Q3 2022 after selling out during the quarter.
Sutton Wealth Advisors sold 5 Integra LifeSciences shares in Q3 2022, an estimated $256.
Sutton Wealth Advisors first reported a position in Integra LifeSciences in Q1 2016 and held it in 15 quarters.
Sutton Wealth Advisors's Integra LifeSciences position peaked at $54.7K in Q1 2018.
282 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2022.

Based on Sutton Wealth Advisors's 13F filing for Q3 2022, filed 7 Nov 2023.